Benzinga's Top Upgrades, Downgrades For May 27, 2020

Loading...
Loading...

Upgrades

  • Evercore ISI Group upgraded the stock for Dentsply Sirona Inc XRAY from In-Line to Outperform. In the first quarter, Dentsply Sirona showed an EPS of $0.43, compared to $0.49 from the year-ago quarter. The stock has a 52-week-high of $60.87 and a 52-week-low of $31.57. Dentsply Sirona's stock last closed at $45.33 per share.
  • For NIO Inc NIO, JP Morgan upgraded the stock from Underweight to Neutral. NIO earned ($0.39) in the fourth quarter, compared to ($0.47) in the year-ago quarter. The stock has a 52-week-high of $5.65 and a 52-week-low of $1.19. NIO's stock last closed at $3.83 per share.
  • For Sensata Technologies Holding PLC ST, Morgan Stanley upgraded the stock from Underweight to Equal-Weight. Sensata Technologies earned $0.53 in the first quarter, compared to $0.85 in the year-ago quarter. The stock has a 52-week-high of $54.72 and a 52-week-low of $18.25. Sensata Technologies's stock last closed at $36.37 per share.
  • Goldman Sachs changed the rating for Jack In The Box Inc JACK from Sell to Neutral. For the second quarter, Jack In The Box had an EPS of $0.50, compared to year-ago quarter EPS of $0.99. The stock has a 52-week-high of $93.12 and a 52-week-low of $16.81. Jack In The Box's stock last closed at $65.31 per share.
  • Morgan Stanley changed the rating for Bilibili Inc BILI from Equal-Weight to Overweight. Bilibili earned ($0.20) in the first quarter, compared to ($0.06) in the year-ago quarter. The stock has a 52-week-high of $36.47 and a 52-week-low of $13.23. Bilibili's stock last closed at $33.13 per share.
  • MKM Partners upgraded the stock for AMC Entertainment Holdings Inc AMC from Sell to Neutral. For the fourth quarter, AMC Entertainment had an EPS of $0.35, compared to year-ago quarter EPS of $0.18. The stock has a 52-week-high of $13.06 and a 52-week-low of $1.95. AMC Entertainment's stock last closed at $5.10 per share.
  • JP Morgan upgraded the stock for TransDigm Group Inc TDG from Underweight to Neutral. In the second quarter, TransDigm Gr showed an EPS of $5.10, compared to $4.21 from the year-ago quarter. The stock has a 52-week-high of $673.51 and a 52-week-low of $200.06. TransDigm Gr's stock last closed at $402.58 per share.

 

Downgrades

  • For Merus NV MRUS, RBC Capital downgraded the stock from Outperform to Sector Perform. Merus earned ($0.68) in the first quarter, compared to ($0.29) in the year-ago quarter. The stock has a 52-week-high of $20.95 and a 52-week-low of $10.19. Merus's stock last closed at $15.36 per share.
  • Deutsche Bank downgraded the stock for LATAM Airlines Group SA LTM from Hold to Sell. LATAM Airlines Group earned $0.37 in the fourth quarter, compared to $0.25 in the year-ago quarter. The stock has a 52-week-high of $12.15 and a 52-week-low of $1.00. LATAM Airlines Group's stock last closed at $1.68 per share.
  • Stifel changed the rating for Bio-Techne Corp TECH from Buy to Hold. In the third quarter, Bio-Techne showed an EPS of $1.39, compared to $1.21 from the year-ago quarter. The stock has a 52-week-high of $282.52 and a 52-week-low of $155.17. Bio-Techne's stock last closed at $260.65 per share.
  • Barclays downgraded the stock for Pinduoduo Inc PDD from Overweight to Equal-Weight. Pinduoduo earned ($0.39) in the first quarter, compared to ($0.20) in the year-ago quarter. The stock has a 52-week-high of $69.69 and a 52-week-low of $18.46. Pinduoduo's stock last closed at $64.89 per share.
  • For Hyatt Hotels Corp H, Baird downgraded the stock from Outperform to Neutral. In the first quarter, Hyatt Hotels showed an EPS of ($0.35), compared to $0.45 from the year-ago quarter. The stock has a 52-week-high of $94.98 and a 52-week-low of $24.02. Hyatt Hotels's stock last closed at $56.54 per share.
  • Mizuho changed the rating for FirstEnergy Corp FE from Buy to Neutral. FirstEnergy earned $0.66 in the first quarter, compared to $0.67 in the year-ago quarter. The stock has a 52-week-high of $52.52 and a 52-week-low of $32.00. FirstEnergy's stock last closed at $40.70 per share.
  • For Pearson PLC PSO, Berenberg downgraded the stock from Hold to Sell. The stock has a 52-week-high of $11.51 and a 52-week-low of $5.08. Pearson's stock last closed at $5.75 per share.

 

Initiations

  • Alliance Global Partners initiated coverage on PDS Biotechnology Corp PDSB with a Buy rating. The price target for PDS Biotechnology is set at $4.00. In the first quarter, PDS Biotechnology showed an EPS of ($0.39), compared to ($1.06) from the year-ago quarter. The stock has a 52-week-high of $7.84 and a 52-week-low of $0.62. PDS Biotechnology's stock last closed at $1.17 per share.
  • Deutsche Bank initiated coverage on Chipotle Mexican Grill Inc CMG with a Hold rating. The price target for Chipotle Mexican Grill is set at $1132.00. Chipotle Mexican Grill earned $3.08 in the first quarter, compared to $3.40 in the year-ago quarter. The stock has a 52-week-high of $1087.00 and a 52-week-low of $415.00. Chipotle Mexican Grill's stock last closed at $1016.80 per share.
  • With a rating of Overweight, Wells Fargo initiated coverage on ChemoCentryx Inc CCXI. The price target is set at $79.00 for ChemoCentryx. ChemoCentryx earned ($0.35) in the first quarter, compared to ($0.23) in the year-ago quarter. The stock has a 52-week-high of $61.25 and a 52-week-low of $6.16. ChemoCentryx's stock last closed at $59.20 per share.
  • For Pacira BioSciences Inc PCRX, Guggenheim initiated coverage, by setting the current rating at Neutral. Pacira BioSciences earned $0.53 in the first quarter, compared to $0.22 in the year-ago quarter. The stock has a 52-week-high of $51.35 and a 52-week-low of $27.46. Pacira BioSciences's stock last closed at $44.54 per share.
  • With a rating of Buy, Guggenheim initiated coverage on Heron Therapeutics Inc HRTX. The price target is set at $24.00 for Heron Therapeutics. For the first quarter, Heron Therapeutics had an EPS of ($0.57), compared to year-ago quarter EPS of ($0.80). The stock has a 52-week-high of $26.81 and a 52-week-low of $9.60. Heron Therapeutics's stock last closed at $18.44 per share.
  • With a rating of Buy, Jefferies initiated coverage on Freshpet Inc FRPT. The price target is set at $86.00 for Freshpet. Freshpet earned ($0.07) in the first quarter, compared to ($0.10) in the year-ago quarter. The stock has a 52-week-high of $81.29 and a 52-week-low of $35.95. Freshpet's stock last closed at $70.92 per share.
  • With a rating of Buy, Guggenheim initiated coverage on Flexion Therapeutics Inc FLXN. The price target is set at $20.00 for Flexion Therapeutics. In the first quarter, Flexion Therapeutics showed an EPS of ($0.95), compared to ($1.09) from the year-ago quarter. The stock has a 52-week-high of $22.98 and a 52-week-low of $5.01. Flexion Therapeutics's stock last closed at $9.69 per share.
  • BTIG initiated coverage on Donnelley Financial Solutions Inc DFIN with a Buy rating. The price target for Donnelley Financial Solns is set at $11.00. Donnelley Financial Solns earned $0.21 in the first quarter, compared to $0.06 in the year-ago quarter. The stock has a 52-week-high of $14.77 and a 52-week-low of $4.04. Donnelley Financial Solns's stock last closed at $7.84 per share.
  • For Collegium Pharmaceutical Inc COLL, Guggenheim initiated coverage, by setting the current rating at Neutral. For the first quarter, Collegium Pharmaceutical had an EPS of $0.01, compared to year-ago quarter EPS of ($0.29). The stock has a 52-week-high of $25.59 and a 52-week-low of $10.01. Collegium Pharmaceutical's stock last closed at $23.43 per share.
Loading...
Loading...
date
ticker
name
Price Target
Upside/Downside
Recommendation
Firm
Posted In: Penny StocksUpgradesDowngradesInitiationIntraday UpdateAnalyst RatingsConsumer DiscretionaryInitiationsLeisure Facilitiestop upgrades
We simplify the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

Loading...